Primary sclerosing cholangitis is protective against non-alcoholic fatty liver disease in inflammatory bowel disease
Human Pathology Oct 05, 2017
Bosch DE, et al. - This study examined the role of primary sclerosing cholangitis (PSC) on the non-alcoholic fatty liver disease (NAFLD). The findings exhibited that despite similar prevalence of major NAFLD risk factors, patients with co-morbid inflammatory bowel disease (IBD) and PSC reported considerably less susceptibility to NAFLD than those with IBD alone.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries